Comparison

CYC-116 European Partner

Item no. TMO-T6458-5mg
Manufacturer TargetMol
CASRN 693228-63-6
Amount 5 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles Cc1nc(N)sc1-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
CDK|||Aurora Kinase|||VEGFR|||FLT|||S6 Kinase
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
368.46
Description
CYC116 is a potent inhibitor of Aurora A/B with Ki of 8.0 nM/9.2 nM, is less potent to VEGFR2 (Ki of 44 nM), with 50-fold greater potency than CDKs, not active against PKA, Akt/PKB, PKC, no effect on GSK-3α/β, CK2, Plk1 and SAPK2A. Phase 1.
Pathways
MAPK|||Chromatin/Epigenetic|||PI3K/Akt/mTOR signaling|||Tyrosine Kinase/Adaptors|||Cell Cycle/Checkpoint|||Angiogenesis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close